GlycoMimetics
GLYC
#10327
Rank
C$13.99 M
Marketcap
C$0.22
Share price
-5.42%
Change (1 day)
-46.66%
Change (1 year)

GlycoMimetics (GLYC) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : C$3.61 Million

According to GlycoMimetics 's latest financial reports the company's total liabilities are C$3.61 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlycoMimetics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$8.29 M-9.43%
2023-12-31C$9.15 M-24.03%
2022-12-31C$12.05 M-25.8%
2021-12-31C$16.24 M-12.84%
2020-12-31C$18.63 M3.61%
2019-12-31C$17.98 M40.82%
2018-12-31C$12.77 M14.36%
2017-12-31C$11.16 M17.25%
2016-12-31C$9.52 M-14.08%
2015-12-31C$11.08 M47.85%
2014-12-31C$7.49 M196.42%
2013-12-31C$2.52 M-56.83%
2012-12-31C$5.85 M-71.84%
2011-12-31C$20.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
bluebird bio
BLUE
C$0.48 B 13,420.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 4,418,627.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$91.21 B 2,522,974.75%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
C$156.85 B 4,338,533.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$13.97 M 286.54%๐Ÿ‡บ๐Ÿ‡ธ USA